To assess whether TILs in ovarian carcinomas carried clonal TCR gene rearrangements, thereby indicating a potential recognition of a specific tumour cell antigen, we analysed TCRγ genes using the Biomed-2 protocol (van Dongen et al, 2003). The gene discussed is TRGC1; the disease is neoplasm.